GSK
EMA begin review of GSK & Vir COVID-19 treatment
May 10, 2021Sales and Marketing COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir
The EMA has begun a rolling review of GSK and Vir’s sotrovimab treatment for COVID-19, which will continue until there …
GSK lupus treatment approved by European Commission
May 6, 2021GSK, Lupus, lupus treatment, pharma, pharma news
GSK’s Benlysta treatment, for patients with active lupus nephritis (LN) in addition to systemic lupus erythematosus (SLE), has been approved …
EMA to begin review of GSK and Vir’s COVID-19 treatment
April 16, 2021Medical Communications COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir
The EMA have begun a review of GSK and Vir Biotechnology’s investigational COVID-19 antibody (VIR-7831) for patients at high risk …
GSK to support manufacture of 60m Novavax COVID-19 vaccines
March 30, 2021Manufacturing and Production COVID-19, GSK, UK, Vaccine
GSK has reached an agreement with Novavax and the UK Government Vaccines Taskforce to support the production of up to …
GSK & Vir’s COVID-19 treatment shows 85% efficacy in Phase III trial
March 29, 2021Sales and Marketing COVID-19, GSK, Phase III trial, covid-19 treatment, vir
GSK and Vir Biotechnology have submitted an Emergency Use Authorization request to the FDA for their VIR-7831 therapy for the …
GSK starts Phase III study for severe asthma treatment
March 18, 2021GSK, asthma, phase III
GSK has announced today that the first patient has been dosed in part of their Phase III clinical trial investigating …
Medicago & GSK start plant-derived COVID-19 vaccine trial
March 17, 2021Research and Development COVID-19, GSK
Medicago and GSK have announced the start of Phase III clinical testing of Medicago’s plant-derived COVID-19 vaccine. The vaccine candidate …
GSK and Vir Biotechnology COVID-19 drug found to reduce deaths and hospitalisation by 85%
March 11, 2021GSK, GlaxoSmithKline, Vir Biotechnology
Vir Biotechnology and GSK have announced that their monoclonal-antibody drug has been found to reduce hospitalisations or deaths from COVID-19 …
GSK’s Phase II otilimab study on COVID-19 patients promising for over-70s
February 26, 2021Medical Communications COVID-19, GSK, coronavirus, covid-19 treatment, otilimab
GlaxoSmithKline’s (GSK) Phase II OSCAR study of their otilimab antibody’s effect on COVID-19 patients has shown promising results in older …
GSK and Sanofi to begin new Phase II trial of their COVID-19 vaccine
February 22, 2021Sales and Marketing COVID, COVID Vaccine, COVID-19, GSK, Sanofi
GlaxoSmithKline (GSK) and Sanofi are set to begin a new Phase II study of their COVID-19 vaccine candidate, following setbacks …
Sanofi/GSK COVID-19 vaccine development delayed after failing to induce strong response in over-50s
December 11, 2020Medical Communications, Research and Development COVID-19, GSK, Sanofi, Vaccine
Sanofi and GlaxoSmithKline have taken the decision to delay the development programme for their adjuvanted recombinant protein-based COVID-19 vaccine after …
Pharmafile.com’s weekly COVID-19 news round-up
November 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK, US, remdesivir
As European nations fall one by one back into lockdown, hopes weigh heavily on a vaccine to pave a path …
GSK and Sanofi promise 200m COVID-19 vaccines to international COVAX initiative
October 28, 2020Manufacturing and Production, Research and Development COVAX, COVID-19, GSK, Sanofi
Sanofi and GSK have committed 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine to the COVAX Facility, a …
GSK tells UK staff to turn off NHS COVID-19 tracking app while at work
October 7, 2020Research and Development COVID, GSK, covid app
GlaxoSmithKline has told its employees to turn off the new NHS coronavirus tracking app at work as it could be …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
